We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The drug maker plans to use the proceeds of the sale, combined with the $1.1 billion it received from the recent sale of its Paragard IUD asset announced last week, to pay down debt